Cantàfora A, Blotta I, Bruzzese N, Calandra S, Bertolini S
Istituto Superiore di Sanità, Roma, Italy.
Electrophoresis. 2001 Oct;22(18):4012-5. doi: 10.1002/1522-2683(200110)22:18<4012::AID-ELPS4012>3.0.CO;2-X.
This study evaluated the applicability of microchip electrophoresis to the sizing of microsatellites suitable to genetic, clinical and forensic applications. The evaluation was performed with the D19S394 tetranucleotide (AAAG) repeat characterized by a wide variation in the repeat number (1-17) and a short recombination distance from the low-density lipoprotein (LDL)-receptor gene that makes it suitable to cosegregation analysis of familial hypercholesterolemia (FH). The study was performed with 70 carriers of two LDL-receptor mutations common in northern Italy (i.e., the 4 bp insertion in exon 10 known as FH-Savona and the D200G missense mutation in the exon 4, known as FH-Padova 1) and 100 healthy controls. The polymerase chain reaction (PCR) amplification products prepared with a cosolvent PCR protocol and an antibody-protected polymerase were directly analyzed with an apparatus for high-voltage capillary electrophoresis on microchips and laser-induced fluorescence detection equipped with chips for the analysis of 25-500 bp dsDNA fragments. The test could not be extended to dinucleotide repeats due to the resolution characteristics of the available microchip. This novel approach was able to distinguish 17 microsatellite alleles varying from 0 to 17 repeats. Many of these alleles were quite rare, but the seven more abundant accounted for over the 70% of allele distribution in control population. The standard deviation in the sizing of the most abundant alleles ranged from +0.60 to +/- 0.75 bp. This indicated that the size attribution to a conventional allele using the +/- 1 bp range around it allowed a confidence limit above the 80 %. The sizing of D19S394 obtained this way allowed the cosegregation analysis with both the FH mutations tested. Therefore, this innovative approach to microsatellite sizing was much simpler, but equally effective as traditional capillary electrophoresis, at least with tetranucleotide repeats.
本研究评估了微芯片电泳在适合遗传、临床和法医应用的微卫星分型中的适用性。评估使用了D19S394四核苷酸(AAAG)重复序列,其重复次数变化范围广(1 - 17),且与低密度脂蛋白(LDL)受体基因的重组距离短,这使得它适用于家族性高胆固醇血症(FH)的共分离分析。该研究对70名意大利北部常见的两种LDL受体突变携带者(即外显子10中的4 bp插入,称为FH - 萨沃纳;外显子4中的D200G错义突变,称为FH - 帕多瓦1)和100名健康对照进行。用含有助溶剂的PCR方案和抗体保护的聚合酶制备的聚合酶链反应(PCR)扩增产物,直接通过配备用于分析25 - 500 bp双链DNA片段芯片的高压毛细管电泳微芯片仪器和激光诱导荧光检测进行分析。由于现有微芯片的分辨率特性,该测试无法扩展到二核苷酸重复序列。这种新方法能够区分17个微卫星等位基因,其重复次数从0到17不等。其中许多等位基因相当罕见,但7个丰度较高的等位基因占对照人群等位基因分布的70%以上。最丰富等位基因分型的标准偏差范围为±0.60至±0.75 bp。这表明,使用其周围±1 bp范围对常规等位基因进行大小归属,置信限高于80%。以这种方式获得的D19S394分型允许与所测试的两种FH突变进行共分离分析。因此,这种微卫星分型的创新方法更简单,但至少对于四核苷酸重复序列,与传统毛细管电泳同样有效。